TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
Home›ISPC›Financials
Annual statements · SEC XBRL · FY2020 – FY2025

iSpecimen Inc. (ISPC) financials

Income statement

iSpecimen Inc. (ISPC) income statement, annual, from SEC filings
Fiscal yearFY2020FY2021FY2022FY2023FY2024FY2025
Revenue$8.18M$11.1M$10.4M$9.93M$9.29M$1.93M
Revenue growth—36.1%-6.6%-4.6%-6.4%-79.2%
Operating income-$2.41M-$5.93M-$10.2M-$11.2M-$12.7M-$8.98M
Operating margin-29.4%-53.2%-97.9%-112.5%-137.0%-465.4%
Net income-$4.65M-$8.96M-$10.2M-$11.1M-$12.5M-$10.5M
Net margin-56.8%-80.5%-98.5%-111.8%-134.5%-543.7%
EPS (diluted)-$4.97-$2.09-$1.16-$24.55-$17.58-$2.28

Cash flow

iSpecimen Inc. (ISPC) cash flow, annual, from SEC filings
Fiscal yearFY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow-$288K-$10.7M-$5.82M-$5.81M-$8.26M-$4.24M
Capital expenditures$426.00$2.55K$216K$19.5K$31.5K$454.00
Free cash flow-$289K-$10.7M-$6.03M-$5.83M-$8.30M-$4.24M

Balance sheet

iSpecimen Inc. (ISPC) balance sheet, annual, from SEC filings
Fiscal yearFY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$696K$27.7M$15.3M$2.34M$1.88M$6.88M
Total assets$6.21M$35.7M$24.6M$15.8M$9.35M$9.53M
Total liabilities$22.3M$5.93M$4.31M$6.08M$6.04M$6.44M
Long-term debt—$3.42M————
Shareholders' equity-$27.3M$29.8M$20.3M$9.74M$3.31M$3.09M
Retained earnings-$29.1M-$38.0M-$48.3M-$59.4M-$71.9M-$82.4M
Shares (wtd avg diluted)936K4.29M8.84M452K711K4.60M

Every figure is extracted from iSpecimen Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.

Common questions

What is iSpecimen Inc.'s annual revenue?
iSpecimen Inc. (ISPC) reported $1.93M of revenue for fiscal year 2025 — down 79.2% from $9.29M in FY2024, per its annual report filed with the SEC.
Is iSpecimen Inc. profitable?
Not in FY2025 — ISPC reported a net loss of $10.5M, per SEC filings.
What is iSpecimen Inc.'s free cash flow?
-$4.24M in FY2025 (operating cash flow -$4.24M minus $454.00 of capital expenditures), from the SEC cash-flow statement.
Does ISPC pay a dividend?
iSpecimen Inc. reported no cash dividends paid in FY2025, per its SEC cash-flow statement.
Full ISPC analysis — verdict, score & filings →Is ISPC a buy? →

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.